Investigation of Human Albumin-Induced Circular Dichroism in Dansylglycine

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Graciani, Fernanda S ^a   Ximenes, Valdecir F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINO ACID; DANSYLGLYCINE; GLYCINE; HUMAN SERUM ALBUMIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHIRALITY; CIRCULAR DICHROISM; COMPLEX FORMATION; CONTROLLED STUDY; INDUCED CIRCULAR DICHROISM; OXIDATION; PH; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TEMPERATURE SENSITIVITY;

CIRCULAR DICHROISM; FLUORESCENCE; GLYCINE; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; LIGANDS; OXIDATION-REDUCTION; PROTEIN BINDING; PROTEIN DENATURATION; SERUM ALBUMIN; TEMPERATURE;

EID: 84885789435     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076849     Document Type: Article

References (40)

1. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, et al. (2012) Human serum albumin: from bench to bedside. Mol Aspects Med 33(3): 209-290.
2. Ryan AJ, Ghuman J, Zunszain PA, Chung CW, Curry S, (2011) Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin. J Struct Biol 174(1): 84-91.
3. Sudlow G, Birkett DJ, Wade DN, (1975) The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 11: 824-832.
4. Sudlow G, Birkett DJ, Wade DN, (1976) Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12: 1052-1061.
5. Fehske KJ, Schhtfer U, Wollert U, Mtiller WE, (1982) Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. Mol Pharmacol 21(2): 387-393.
6. Bree F, Urien S, Nguyen P, Albengres E, Tillement JP, (1990) A re-evaluation of the HSA-piroxicam interaction. Eur J Drug Metab. Pharmacokinet 15: 303-307.
7. Macia{ogonek}żek-Jurczyk M, Sułkowska A, Bojko B, Równicka-Zubik J, Sułkowski WW, (2011) A spectroscopic study of phenylbutazone and aspirin bound to serum albumin in rheumatoid diseases. Spectrochim Acta A Mol Biomol Spectrosc 82(1): 181-190.
8. Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S, (2005) Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 353(1): 38-52.
9. Rosenbaum SE (2011) Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook and Computer Simulations. Wiley. 448 p.
10. Zhang X, Li L, Xu Z, Liang Z, Su J, et al. (2013) Investigation of the interaction of naringin palmitate with bovine serum albumin: spectroscopic analysis and molecular docking. PLoS One 8(3). Epub 2013 Mar 20.
11. Thumser AE, Buckland AG, Wilton DC, (1998) Monoacylglycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site. J Lipid Res 39(5): 1033-1038.
12. Dömötör O, Hartinger CG, Bytzek AK, Kiss T, Keppler BK, et al. (2012) Characterization of the binding sites of the anticancer ruthenium(III) complexes KP1019 and KP1339 on human serum albumin via competition studies. J Biol Inorg Chem. 18(1): 9-17.
13. Marin M, Lhiaubet-Vallet V, Miranda MA, (2011) Site-dependent photo-fries rearrangement within serum albumins. J Phys Chem B. 115(12): 2910-2915.
14. Muller N, Lapicque F, Drelon E, Netter P, (1994) Binding sites of fluorescent probes on human serum albumin. J Pharm Pharmacol 46(4): 300-304.
15. Lakowicz JR (2006) Principles of Fluorescence Spectroscopy. Springer. 954p.
16. Liu X, Du Y, (2010) Study on the binding of chiral drug duloxetine hydrochloride to human serum albumin. Eur J Med Chem 45(9): 4043-4049.
17. Pistolozzi M, Bertucci C, (2008) Species-dependent stereoselective drug binding to albumin: a circular dichroism study. Chirality 20(3-4): 552-558.
18. Bos OJ, Remijn JP, Fischer MJ, Wilting J, Janssen LH, (1988) Location and characterization of the warfarin binding site of human serum albumin. A comparative study of two large fragments. Biochem Pharmacol 37(20): 3905-3909.
19. Nozaki A, Hori M, Kimura T, Ito H, Hatano T, (2009) Interaction of polyphenols with proteins: binding of (-)-epigallocatechin gallate to serum albumin, estimated by induced circular dichroism. Chem Pharm Bull (Tokyo) 57(2): 224-228.
20. Di Bari L, Ripoli S, Pradhan S, Salvadori P, (2010) Interactions between quercetin and warfarin for albumin binding: A new eye on food/drug interference. Chirality 22(6): 593-596.
21. Ace CN, Vajdos F, Fee L, Grimsley G, Gray T, (1995) How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4: 2411-2423.
22. Roy, S. Fluorescence quenching methods to study protein-nucleic acid interactions. Methods Enzymol. 2004, 379, 175-187.
23. Ximenes VF, Paino IM, Faria-Oliveira OM, Fonseca LM, Brunetti IL, (2005) Indole ring oxidation by activated leukocytes prevents the production of hypochlorous acid. Braz J Med Biol Res 38(11): 1575-1583.
24. Petrônio MS, Ximenes VF, (2012) Effects of oxidation of lysozyme by hypohalous acids and haloamines on enzymatic activity and aggregation. Biochim Biophys Acta 1824(10): 1090-1096.
25. Ware WR, (1962) Oxygen quenching of fluorescence in solution: an experimental study of the diffusion process. J Phys Chem 66: 455-458.
26. Roy S, (2004) Fluorescence quenching methods to study protein-nucleic acid interactions. Methods Enzymol 379: 175-187.
27. Van de Weert M, Stella L, (2011) Fluorescence quenching and ligand binding: A critical discussion of a popular methodology. J Mol Struct 998(1-3): 144-150.
28. Sun C, Yang J, Wu X, Huang X, Wang F, et al. (2005) Unfolding and refolding of bovine serum albumin induced by cetylpyridinium bromide. Biophys J 88(5): 3518-3524.
29. Qi ZD, Zhang Y, Liao FL, Ou-Yang YW, Liu Y, Yang X, (2008) Probing the binding of morin to human serum albumin by optical spectroscopy. J Pharm Biomed Anal 46(4): 699-706.
30. Faizul FM, Abdul Kadir H, Tayyab S, (2008) Spectroscopic studies on the binding of bromocresol purple to different serum albumins and its bilirubin displacing action. J Photochem Photobiol B 90(1): 1-7.
31. Wu X, Liu J, Wang Q, Xue W, Yao X, Zhang Y, Jin J, (2011) Spectroscopic and molecular modeling evidence of clozapine binding to human serum albumin at subdomain IIA. Spectrochim Acta A Mol Biomol Spectrosc 79(5): 1202-1209.
32. Van der Veen BS, de Winther MP, Heeringa P, (2009) Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11: 2899-2937.
33. Ximenes VF, da Fonseca LM, de Almeida AC, (2011) Taurine bromamine: a potent oxidant of tryptophan residues in albumin. Arch Biochem Biophys 507(2): 315-322.
34. Petrônio MS, Ximenes VF, (2012) Effects of oxidation of lysozyme by hypohalous acids and haloamines on enzymatic activity and aggregation. Biochim Biophys Acta 1824(10): 1090-1096.
35. Petrônio MS, Ximenes VF (2012) Light emission from tryptophan oxidation by hypobromous acid. Luminescence. doi: 10.1002/bio.2445. [Epub ahead of print].
36. Petrônio MS, Fernandes JR, Menezes ML, Ximenes VF, (2013) Oxidation of Bovine Albumin by Hypochlorous and Hypobromous Acids: Structural and Functional Alterations. Br J Pharm Res 3(1): 147-160.
37. Petrônio MS, Ximenes VF (2013) Inhibition of Lysozyme By Taurine Dibromamine. Protein Pept Lett. [Epub ahead of print].
38. Ryan AJ, Ghuman J, Zunszain PA, Chung CW, Curry S, (2011) Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin. J Struct Biol 174(1): 84-91.
39. Chatterjee T, Pal A, Dey S, Chatterjee BK, Chakrabarti P, (2012) Interaction of virstatin with human serum albumin: spectroscopic analysis and molecular modeling. PLOS One 7(5): e37468 doi:10.1371/journal.pone.0037468.
40. Dockal M, Carter DC, Rüker F, (2000) Conformational transitions of the three recombinant domains of human serum albumin depending on pH. J Biol Chem 275(5): 3042-3050.